Robotic Inferior Vena Cava Grafting and Reconstruction


This video was entered by Dr. Daniel Eun in the 2022 KS International Robotic Surgery Innovation Awards, sponsored by the Vattikuti Foundation. It was featured in the Vattikuti Symposium ‘Humans at the Cutting Edge of Robotic Surgery,’ held in Miami, Florida November 19, 2022.


Here is the Abstract:

Title: Robotic Inferior Vena Cava Grafting and Reconstruction
Authors: Matthew Lee, David Strauss, Randall Lee, Naveen Krishnan, Daniel Eun Temple University Hospital, Philadelphia PA, USA


Introduction and Objective: Although oncologic applications of the surgical robot have become commonplace, its true strength is showcased via complex reconstructive procedures, such as central vessel vascular reconstruction. We demonstrate two cases of inferior vena cava (IVC) robotic assisted laparoscopic (RAL) reconstruction using synthetic grafts.

Methods: First, we show a 78-year-old male with cT3b right renal mass undergoing RAL radical nephrectomy and IVC thrombectomy. After interaortocaval dissection, the right renal artery is divided and the left renal vein, suprarenal IVC, and infrarenal IVC are clamped. The mass invaded a 5-centimeter portion of the IVC, necessitating segmental IVC resection. A 6- centimeter PTFE interposition graft was anastomosed to the IVC to re-establish vascular continuity. Next, a 43-year-old female with an OptEaseTM IVC filter that had eroded through the IVC, deviating the right ureter, required IVC reconstruction. The IVC was clamped proximally and distally. A cavotomy was made and the filter was removed piecemeal. After anterior IVC excision, an 8-centimeter segment of PTFE graft was sutured to the defect as an onlay patch graft.

Results: IVC cross clamp time was 108 and 132 minutes, respectively. Length of stay was 6 and 5
days, respectively. Neither patient had any vascular based complications and were discharged home.

Conclusion: We demonstrate that RAL management of complex IVC pathologies requiring IVC reconstruction with synthetic grafts may be safe, feasible, and effective.


See more at:

KS Awards, Robotics